| Literature DB >> 34326834 |
Tingting Zhu1,2,3, Qun Su4, Cuili Wang1,2,3, Lingling Shen1,2,3, Hongjun Chen1,2,3, Shi Feng1,2,3, Xiaofeng Peng1,2,3, Siyu Chen1,2,3, Yucheng Wang1,2,3, Hong Jiang1,2,3, Jianghua Chen1,2,3.
Abstract
Sepsis is a heterogeneous syndrome induced by infection and results in high mortality. Even though more than 100 biomarkers for sepsis prognosis were evaluated, prediction of patient outcomes in sepsis continues to be driven by clinical signs because of unsatisfactory specificity and sensitivity of these biomarkers. This study aimed to elucidate the key candidate genes involved in sepsis response and explore their downstream effects based on weighted gene co-expression network analysis (WGCNA). The dataset GSE63042 with sepsis outcome information was obtained from the Gene Expression Omnibus (GEO) database and then consensus WGCNA was conducted. We identified the hub gene SDF4 (stromal cell derived factor 4) from the M6 module, which was significantly associated with mortality. Subsequently, two datasets (GSE54514 and E-MTAB-4421) and cohort validation (n=89) were performed. Logistic regression analysis was used to build a prediction model and the combined score resulting in a satisfactory prognosis value (area under the ROC curve=0.908). The model was subsequently tested by another sepsis cohort (n=70, ROC= 0.925). We next demonstrated that endoplasmic reticulum (ER) stress tended to be more severe in patients PBMCs with negative outcomes compared to those with positive outcomes and SDF4 was related to this phenomenon. In addition, our results indicated that adenovirus-mediated Sdf4 overexpression attenuated ER stress in cecal ligation and puncture (CLP) mice lung. In summary, our study indicates that incorporation of SDF4 can improve clinical parameters predictive value for the prognosis of sepsis, and decreased expression levels of SDF4 contributes to excessive ER stress, which is associated with worsened outcomes, whereas overexpression of SDF4 attenuated such activation.Entities:
Keywords: CLP; SDF4; endoplasmic reticulum stress; gene co-expression network; prognosis; sepsis
Year: 2021 PMID: 34326834 PMCID: PMC8313857 DOI: 10.3389/fimmu.2021.659193
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 7.561
Figure 1(A) Sample clustering to detect outliers. All samples were in the clusters and there was no outlier. (B) Analysis of network topology for different soft‐thresholding powers. The soft-thresholding power of 10 was selected for scale-free topology construction. (C) Clustering dendrogram of genes with dissimilarity based on the topological overlap, together with assigned module colors. (D) Eigengene adjacency heatmap. The color of column and row square represents the adjacency of corresponded modules. In the heatmap, red represents high adjacency (positive correlation), while blue color represents low adjacency (negative correlation). Squares of red color along the diagonal are the meta‐module. (E) Network heatmap plot of 1000 randomly-selected genes. Light color represents low overlap and darker color represents higher overlap. The gene dendrogram and module assignment are also shown along the left side and the top.
Figure 2(A) Module-trait associations. Each row corresponds to a module eigengene, and each column corresponds to a trait. Each cell contains the corresponding correlation and P-value. The table is color-coded by correlation according to the color legend. (B) Correlation between module membership and gene significance in the M7 module. (C) Correlation between module membership and gene significance in the M6 module. (D) Correlation between module membership and gene significance in the M3 module. (E) Identification of the hub gene in the intersection of MCC TOP20, DEGs, and GS > 0.2, and MM > 0.8. (F) SDF4 expression in survivors compared to non-survivors in the validation dataset E-MTAB-421. (G) SDF4 expression in survival compared to death in validation dataset GSE54514. **p < 0.01, *p < 0.05.
Characteristics of patients included in the study.
| Characteristic | Survivors (n=68) | Non-survivors (n=21) |
|
|---|---|---|---|
| Demographics | |||
| Age (years) | 59.1 (16.7) | 63.7 (14.5) | 0.25 |
| Male sex | 47 (69.1%) | 13 (61.9%) | 0.54 |
| Smoking | 25 (36.8%) | 12 (57.1%) | 0.10 |
| Chronic comorbidity | |||
| Hypertension | 34 (50.0%) | 10 (47.6%) | 0.85* |
| Diabetes | 12 (17.6%) | 5 (23.8%) | 0.53* |
| Chronic kidney disease | 9 (13.2%) | 8 (38.1%) |
|
| Cardiac failure | 8 (11.8%) | 1 (4.8%) | 0.35* |
| Chronic liver disease | 5 (7.4%) | 3 (14.3%) | 0.33* |
| Cancer | 17 (25.0%) | 11 (52.4%) |
|
| Infection | |||
| Gram-positive bacteria | 3 (4.4%) | 0 (0%) | 0.33* |
| Gram-negative bacteria | 4 (5.9%) | 2 (9.5%) | 0.56* |
| Viral | 1 (1.5%) | 1 (4.8%) | 0.37* |
| Fungus | 5 (7.4%) | 4 (19.0%) | 0.12* |
| Severity at time of admission to ICU | |||
| APACHE II score | 15.8 (5.4) | 20.1 (6.3) |
|
| SOFA score | 6.1 (3.3) | 9.5 (3.1) |
|
| Laboratory data | |||
| WBC (×109/L) | 12.1 (6.6) | 12.6(9.9) | 0.80 |
| Neutrophil (%) | 85.3 (10.9) | 88.9 (6.6) | 0.16 |
| Lymphocyte (%) | 7.7 (6.5) | 7.0 (5.0) | 0.65 |
| Monocyte (%) | 5.4 (3.5) | 4.6 (3.3) | 0.39 |
| CRP (mg/L) | 89.0 (73.9) | 94.2 (83.0) | 0.79 |
| PCT (ng/mL) | 6.7 (19.8) | 2.0 (0.5) | 0.29 |
| Lactate (mmol/L) | 1.5 (0.8) | 1.9 (0.7) | 0.09 |
Data are n (%) or mean (SD). APACHE II, Acute Physiology and Chronic Health Evaluation II; SOFA, Sequential Organ Failure Assessment; CRP, C‐reactive protein; PCT, procalcitonin. Statistical analysis t test unless otherwise specified. *χ² test. Bold denotes statistical difference.
Figure 3(A) SDF4 expression in survivors (n=68) compared to non-survivors (n=21) within the cohort. (B) APACHE II score in survivors compared to non-survivors. (C) SOFA score in survivors compared to non-survivors. (D) Combined score in survivors compared to non-survivors. (E) CRP in survivors compared to non-survivors. (F) PCT in survivors compared to non-survivors. (G) Lactate in survivors compared to non-survivors. (H) Receiver operating characteristics (ROC) curve of a diagnostic test based on SDF4 expression, APACHE II score, SOFA score, combined score, CRP, PCT, and lactate. ****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05. NS, not significant.
Results of multivariate logistic regression modeling.
| Characteristic | n = 89 | ||
|---|---|---|---|
| HR | 95% CI |
| |
| SDF4 expression level | 0.165 | 0.054-0.508 | 0.002 |
| APACHE II score | 1.131 | 0.982-1.302 | 0.088 |
| SOFA score | 1.381 | 1.126-1.695 | 0.002 |
| Cancer | 24.062 | 3.707-156.183 | 0.001 |
| Chronic kidney disease | 7.289 | 1.404-37.857 | 0.018 |
HR, hazard ratio; CI, confidence interval.
Figure 4(A) SDF4 expression in survival (n=51) compared with death (n=19) in validation cohort. (B) Receiver operating characteristics (ROC) curve of a diagnostic test based on SDF4 (AUC=0.794), APACHE II score (AUC=0.750), SOFA score (AUC=0.751) and combined score (AUC=0.925). (C) Receiver operating characteristics (ROC) curve of a diagnostic test based on CRP (AUC=0.624), PCT (AUC=0.659), lactate (AUC=0.752) and combined score. ***p < 0.001.
Figure 5(A) Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis of DEGs (p < 0.05). (B) Representative TEM picture in survival and death. (C) Representative photomicrographs showing SDF4 (green), DAPI (blue) and their merged images (original magnification ×400). Scale bar, 100um. (D) GRP78 expression in survival (n=68) compared with death (n=21) in cohort. (E) Pearson correlation analysis between the expression level of GRP78 and SDF4 in cohort. (F) Pearson correlation analysis between the expression level of ATF6 and SDF4 in cohort. (G) Representative histograms of CHOP expression among survival and death in flow cytometry. (H) Mean fluorescence intensity of CHOP in survival (n=54) and death (n=19). (I) Representative histograms of ATF6 expression among survival and death in flow cytometry. (J) Mean fluorescence intensity of ATF6 in survival and death. (K) Representative histograms of GRP78 expression among survival and death in flow cytometry. (L) Mean fluorescence intensity of GRP78 in survival and death. (M) Representative photomicrographs showing CHOP (red), DAPI (blue) and their merged images (original magnification ×400). Scale bar, 100um. (N) Representative photomicrographs showing ATF6 (green), DAPI (blue) and their merged images (original magnification ×400). (O) Representative photomicrographs showing GRP78 (red), DAPI (blue) and their merged images (original magnification ×400). ***p < 0.001, **p < 0.01, *p < 0.05.
Figure 6(A). Representative western blot results from sham-operated and CLP mice lung for levels of cleaved- Atf6, Grp78, Chop, and β-actin. (B–E) The cleaved- Atf6, Grp78 and Chop bands were quantified by densitometry and normalized to the density of β-actin. n=5. Data were shown in Mean ± SD. ***p < 0.001, **p < 0.01, *p < 0.05.
Figure 7(A) Representative photomicrographs of Grp78 and Chop from sham-operated and CLP mice lung treated with AdCon or AdSdf4 (original magnification ×400). Scale bar, 100um. (B, C) Positive staining area of Grp78 and Chop from four groups. (D) Representative western blot results from four groups for levels of cleaved- Atf6, Grp78, Chop, and β-actin. (E–G) The cleaved- Atf6, Grp78 and Chop bands were quantified by densitometry and normalized to the density of β-actin. n=5. Data were shown in Mean ± SD. ****p < 0.001, ***p < 0.001, **p < 0.01, *p < 0.05.